Clinical Trial Update: MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial [Phase 2]

View source ↗

Summary

Phase 2 trial MRI-MARK evaluating MRI-guided radiation therapy for early-stage renal cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v8 | Phase 2 | Status: WITHDRAWN